Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanoma

Khosravi,Shahram; Martinka,Magdalena; Zhou,Youwen; Ong,Christopher   J.

doi:10.3892/ol.2016.5057

Prognostic significance of the expression of nuclear eukaryotic translation initiation factor 5A2 in human melanoma

Authors:
- Shahram Khosravi
- Magdalena Martinka
- Youwen Zhou
- Christopher J. Ong
View Affiliations

Affiliations: Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada, Department of Pathology, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada, Department of Surgery, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, BC V5Z 1L8, Canada
Published online on: August 29, 2016 https://doi.org/10.3892/ol.2016.5057
Pages: 3089-3100
Copyright: © Khosravi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Eukaryotic translation initiation factor 5A2 (EIF5A2) expression is upregulated in various cancers. The present authors previously demonstrated that cytoplasmic EIF5A2 expression increases with melanoma progression and inversely correlates with patient survival. Other studies have suggested that nuclear EIF5A2 may also play a role in oncogenesis. The present study used immunohistochemistry and tissue microarray with a large number of melanocytic lesions (n=459) and demonstrated that nuclear EIF5A2 expression was significantly upregulated between common acquired nevi, dysplastic nevi and primary melanomas, and between primary melanomas and metastatic melanomas. Nuclear EIF5A2 expression was inversely associated with overall and disease‑specific 5‑year survival rate for all (P<0.001) and primary (P=0.014 and P=0.015, respectively) melanoma patients. Nuclear EIF5A2 expression was directly associated with melanoma thickness (P=0.036) and American Joint Committee on Cancer staging (P<0.001), which suggests the possible role of nuclear EIF5A2 in melanoma cell invasion. Subsequently, the present study investigated the association between the expression of nuclear EIF5A2 and matrix metalloproteinase‑2 (MMP‑2), which is an important factor for promoting cancer cell invasion. Nuclear EIF5A2 and a strong MMP‑2 expression were directly associated, and their concurrent expression was significantly associated with a poorer overall and disease‑specific 5‑year survival rate for all and primary melanoma patients. Nuclear and cytoplasmic EIF5A2 expression were also demonstrated to be significantly associated, and simultaneous expression of the two forms of EIF5A2 was significantly associated with poor overall and disease‑specific 5‑year survival rates for all and primary melanoma patients. Multivariate Cox regression analysis revealed that nuclear EIF5A2 expression alone and in combination with cytoplasmic EIF5A2 expression was an adverse independent prognostic factor for all and primary melanoma patients. In conclusion, the present study for the first time, to the best of our knowledge, demonstrated that nuclear EIF5A2 expression is an independent prognostic marker in melanoma, and revealed its role in melanoma progression and patient survival. Therefore, nuclear EIF5A2 may have the potential to serve as a therapeutic marker for melanoma.

View Figures

View References

1	Miller AJ and Mihm MC Jr: Melanoma. N Engl J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
2	Linos E, Swetter SM, Cockburn MG, Colditz GA and Clarke CA: Increasing burden of melanoma in the United States. J Invest Dermatol. 129:1666–1674. 2009. View Article : Google Scholar : PubMed/NCBI
3	Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL and Chanmugam A: Cutaneous malignant melanoma. Mayo Clin Proc. 81:500–507. 2006. View Article : Google Scholar : PubMed/NCBI
4	Saini P, Eyler DE, Green R and Dever TE: Hypusine-containing protein eIF5A promotes translation elongation. Nature. 459:118–121. 2009. View Article : Google Scholar : PubMed/NCBI
5	Patel PH, Costa-Mattioli M, Schulze KL and Bellen HJ: The Drosophila deoxyhypusine hydroxylase homologue nero and its target eIF5A are required for cell growth and the regulation of autophagy. J Cell Biol. 185:1181–1194. 2009. View Article : Google Scholar : PubMed/NCBI
6	Hauber I, Bevec D, Heukeshoven J, Krätzer F, Horn F, Choidas A, Harrer T and Hauber J: Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest. 115:76–85. 2005. View Article : Google Scholar : PubMed/NCBI
7	Kruse M, Rosorius O, Kratzer F, Bevec D, Kuhnt C, Steinkasserer A, Schuler G and Hauber J: Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J Exp Med. 191:1581–1590. 2000. View Article : Google Scholar : PubMed/NCBI
8	Lipowsky G, Bischoff FR, Schwarzmaier P, Kraft R, Kostka S, Hartmann E, Kutay U and Görlich D: Exportin 4: A mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J. 19:4362–4371. 2000. View Article : Google Scholar : PubMed/NCBI
9	Hutten S and Kehlenbach RH: CRM1-mediated nuclear export: To the pore and beyond. Trends Cell Biol. 17:193–201. 2007. View Article : Google Scholar : PubMed/NCBI
10	Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, Nunemaker CS, Stull ND, Taylor CA, Thompson JE, et al: The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest. 120:2156–2170. 2010. View Article : Google Scholar : PubMed/NCBI
11	Zuk D and Jacobson A: A single amino acid substitution in yeast eIF-5A results in mRNA stabilization. EMBO J. 17:2914–2925. 1998. View Article : Google Scholar : PubMed/NCBI
12	Schrader R, Young C, Kozian D, Hoffmann R and Lottspeich F: Temperature-sensitive eIF5A mutant accumulates transcripts targeted to the nonsense-mediated decay pathway. J Biol Chem. 281:35336–35346. 2006. View Article : Google Scholar : PubMed/NCBI
13	Jenkins ZA, Hååg PG and Johansson HE: Human eIF5A2 on chromosome 3q25-q27 is a phylogenetically conserved vertebrate variant of eukaryotic translation initiation factor 5A with tissue-specific expression. Genomics. 71:101–109. 2001. View Article : Google Scholar : PubMed/NCBI
14	Clement PM, Henderson CA, Jenkins ZA, Smit-McBride Z, Wolff EC, Hershey JW, Park MH and Johansson HE: Identification and characterization of eukaryotic initiation factor 5A-2. Eur J Biochem. 270:4254–4263. 2003. View Article : Google Scholar : PubMed/NCBI
15	Guan XY, Fung JM, Ma NF, Lau SH, Tai LS, Xie D, Zhang Y, Hu L, Wu QL, Fang Y and Sham JS: Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 64:4197–4200. 2004. View Article : Google Scholar : PubMed/NCBI
16	Marchet A, Mocellin S, Belluco C, Ambrosi A, DeMarchi F, Mammano E, Digito M, Leon A, D'Arrigo A, Lise M and Nitti D: Gene expression profile of primary gastric cancer: Towards the prediction of lymph node status. Ann Surg Oncol. 14:1058–1064. 2007. View Article : Google Scholar : PubMed/NCBI
17	Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF and Guan XY: Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol. 39:80–86. 2008. View Article : Google Scholar : PubMed/NCBI
18	Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ, Liao YJ, Bian XW, Lin MC, Kung HF, Zeng YX, et al: Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition. Gut. 61:562–575. 2012. View Article : Google Scholar : PubMed/NCBI
19	Tang DJ, Dong SS, Ma NF, Xie D, Chen L, Fu L, Lau SH, Li Y, Li Y and Guan XY: Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology. 51:1255–1263. 2010. View Article : Google Scholar : PubMed/NCBI
20	Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX and Guan XY: Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol Oncol. 112:314–318. 2009. View Article : Google Scholar : PubMed/NCBI
21	He LR, Zhao HY, Li BK, Liu YH, Liu MZ, Guan XY, Bian XW, Zeng YX and Xie D: Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients. Int J Cancer. 129:143–150. 2011. View Article : Google Scholar : PubMed/NCBI
22	Chen W, Luo JH, Hua WF, Zhou FJ, Lin MC, Kung HF, Zeng YX, Guan XY and Xie D: Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol Biomarkers Prev. 18:400–408. 2009. View Article : Google Scholar : PubMed/NCBI
23	Wei JH, Cao JZ, Zhang D, Liao B, Zhong WM, Lu J, Zhao HW, Zhang JX, Tong ZT, Fan S, et al: EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo. Br J Cancer. 110:1767–1777. 2014. View Article : Google Scholar : PubMed/NCBI
24	Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B, Zender P, Kubicka S, Luk JM, Schirmacher P, et al: An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell. 135:852–864. 2008. View Article : Google Scholar : PubMed/NCBI
25	Khosravi S, Wong RP, Ardekani GS, Zhang G, Martinka M, Ong CJ and Li G: Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion. Br J Cancer. 110:399–408. 2014. View Article : Google Scholar : PubMed/NCBI
26	World Medical Association, . World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 310:2191–2194. 2013. View Article : Google Scholar : PubMed/NCBI
27	Dai DL, Martinka M and Li G: Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases. J Clin Oncol. 23:1473–1482. 2005. View Article : Google Scholar : PubMed/NCBI
28	Zhang Z, Chen G, Cheng Y, Martinka M and Li G: Prognostic significance of RUNX3 expression in human melanoma. Cancer. 117:2719–2727. 2011. View Article : Google Scholar : PubMed/NCBI
29	Chen G, Cheng Y, Tang Y, Martinka M and Li G: Role of Tip60 in human melanoma cell migration, metastasis, and patient survival. J Invest Dermatol. 132:2632–2641. 2012. View Article : Google Scholar : PubMed/NCBI
30	Jafarnejad SM, Ardekani GS, Ghaffari M, Martinka M and Li G: Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion. Oncogene. 32:2131–2139. 2013. View Article : Google Scholar : PubMed/NCBI
31	Soong SJ, Shaw HM, Balch CM, McCarthy WH, Urist MM and Lee JY: Predicting survival and recurrence in localized melanoma: A multivariate approach. World J Surg. 16:191–195. 1992. View Article : Google Scholar : PubMed/NCBI
32	Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, et al: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 27:6199–6206. 2009. View Article : Google Scholar : PubMed/NCBI
33	Gialeli C, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
34	Rotte A, Martinka M and Li G: MMP2 expression is a prognostic marker for primary melanoma patients. Cell Oncol (Dordr). 35:207–216. 2012. View Article : Google Scholar : PubMed/NCBI
35	Wang FW, Guan XY and Xie D: Roles of eukaryotic initiation factor 5A2 in human cancer. Int J Biol Sci. 9:1013–1020. 2013. View Article : Google Scholar : PubMed/NCBI
36	Shaverdashvili K, Wong P, Ma J, Zhang K, Osman I and Bedogni B: MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1. Pigment Cell Melanoma Res. 27:287–296. 2014. View Article : Google Scholar : PubMed/NCBI
37	Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ and van Muijen GN: Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Br J Cancer. 81:774–782. 1999. View Article : Google Scholar : PubMed/NCBI
38	Kurisaki A, Kurisaki K, Kowanetz M, Sugino H, Yoneda Y, Heldin CH and Moustakas A: The mechanism of nuclear export of Smad3 involves exportin 4 and Ran. Mol Cell Biol. 26:1318–1332. 2006. View Article : Google Scholar : PubMed/NCBI
39	Kau TR, Way JC and Silver PA: Nuclear transport and cancer: From mechanism to intervention. Nat Rev Cancer. 4:106–117. 2004. View Article : Google Scholar : PubMed/NCBI